Table 4.
Medication profile at baseline
| Studies | Insulin therapy | Aspirin | Clopidogrel | Statin | Beta-blocker |
|---|---|---|---|---|---|
| Male/female | Male/female | Male/female | Male/female | Male/female | |
| Blondal 2012 [9] | - | 99.4/96.5 | 96.8/90.9 | 76.8/73.9 | 82.6/76.8 |
| Buja 2012 [26] | 30.6/40.7 | - | - | - | - |
| Holland 2013 [12] | - | 91.0/88.0 | 91.0/88.0 | 76.0/73.0 | 72.0/75.0 |
| Lin 2013 [27] | - | - | - | 17.6/19.7 | 43.5/40.1 |
| Michelle 2003 [25] | - | - | - | - | - |
| Younan 2015 [28] | 72.0/68.0 | - | - | 41.0/39.0 | 34.0/38.0 |
| Epps 2016 [29] | - | 96.0/94.4 | - | 68.5/65.9 | 77.0/75.6 |
| Toyota 2013 [30] | 4.10/4.70 | 12.6/13.5 | 7.00/13.0 | 11.4/18.4 | - |
| Cheng 2004 [31] | - | - | - | - | - |
| Eitel 2011 [32] | - | 100/98.0 | 100/98.0 | 98.0/99.0 | 99.0/97.0 |
| Kosuge 2006 [33] | - | - | - | - | - |
| Liu 2015 [11] | - | - | - | - | - |
| Qi 2010 [34] | - | 100/100 | 100/100 | 91.7/91.2 | 71.6/68.6 |
| Roffi 2013 [10] | - | - | - | - | - |
| Zanchi 2009 [35] | - | - | - | - | - |
Data have been reported in percentage